- Home
- KN vs XNCR Comparison
KN vs XNCR Comparison
Compare KN & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KN
- XNCR
- Stock Information
- Founded
- KN 1946
- XNCR 1997
- Country
- KN United States
- XNCR United States
- Employees
- KN N/A
- XNCR N/A
- Industry
- KN Consumer Electronics/Appliances
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- KN Consumer Staples
- XNCR Health Care
- Exchange
- KN Nasdaq
- XNCR Nasdaq
- Market Cap
- KN 1.8B
- XNCR 1.7B
- IPO Year
- KN N/A
- XNCR 2013
- Fundamental
- Price
- KN $20.57
- XNCR $20.45
- Analyst Decision
- KN Hold
- XNCR Strong Buy
- Analyst Count
- KN 1
- XNCR 9
- Target Price
- KN $19.00
- XNCR $36.33
- AVG Volume (30 Days)
- KN 633.3K
- XNCR 766.2K
- Earning Date
- KN 02-05-2025
- XNCR 02-25-2025
- Dividend Yield
- KN N/A
- XNCR N/A
- EPS Growth
- KN N/A
- XNCR N/A
- EPS
- KN N/A
- XNCR N/A
- Revenue
- KN $801,000,000.00
- XNCR $85,164,000.00
- Revenue This Year
- KN $0.38
- XNCR N/A
- Revenue Next Year
- KN N/A
- XNCR $80.86
- P/E Ratio
- KN N/A
- XNCR N/A
- Revenue Growth
- KN 55.62
- XNCR N/A
- 52 Week Low
- KN $14.97
- XNCR $15.31
- 52 Week High
- KN $20.86
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- KN 62.04
- XNCR 38.80
- Support Level
- KN $19.03
- XNCR $19.15
- Resistance Level
- KN $20.86
- XNCR $24.66
- Average True Range (ATR)
- KN 0.41
- XNCR 1.14
- MACD
- KN 0.01
- XNCR -0.37
- Stochastic Oscillator
- KN 84.15
- XNCR 24.96
About KN Knowles Corporation
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in three segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions, Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications and the Consumer MEMS Microphones segment designs and manufactures micro-electro-mechanical systems microphones and audio solutions used in applications. The majority of its revenue comes from the Consumer MEMS Microphones segment.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.